Osaka, Japan

Makoto Kitoh

This inventor holds 2 USPTO granted patents. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Sumitomo Pharmaceuticals Company Limited. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makoto Kitoh. Retrieved from https://idiyas.com/inventor/makoto-kitoh-wdwf2fn5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Makoto Kitoh: Innovator in Pyrrole Derivatives

Introduction

Makoto Kitoh is a distinguished inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrrole derivatives. With a total of 2 patents, his innovations have the potential to impact the pharmaceutical industry.

Latest Patents

One of his latest patents involves a novel pyrrole derivative represented by a specific formula. This compound, along with its salts, exhibits antidiabetic activity, showcasing its potential therapeutic applications. The structural components of the derivative include substituted alkenyl and benzoyl groups, as well as various substituents that enhance its efficacy.

Career Highlights

Throughout his career, Makoto Kitoh has been associated with prominent companies in the pharmaceutical sector. He has worked with Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited, where he has contributed to various research initiatives and product developments.

Collaborations

Makoto has collaborated with notable colleagues, including Ryu Nagata and Kantaro Ushiroda. These partnerships have facilitated the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Makoto Kitoh's work in the field of pyrrole derivatives highlights his role as a key innovator in medicinal chemistry. His contributions are paving the way for new therapeutic options in the treatment of diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…